The director of the National Institute of Allergy and Infectious Diseases stressed that any vaccination would have to overcome several hurdles to prove it is safe and effective before it can be administered to the public.
“If you look at the enrollment projection and the kinds of things you need to decide if the vaccine is safe and protective, most of us predict it will be in November. [or] December, by the end of the year, ”Fauci said.
Drugmaker Pfizer has said it should know by the end of October whether its vaccine is successful, and will then submit it to the Food and Drug Administration for approval.
And reports on Wednesday said the Centers for Disease Control and Prevention told state governors and health officials to be ready to distribute a possible vaccine by November 1.
Meanwhile, Fauci has rejected suggestions that the next presidential election will play a role in the FDA’s decision to give the green light to a vaccine by November.
“The FDA has been very explicit that it will make a decision based on the data received,” he said.
“Data has always been what motivated me and my colleagues at NIH, as well as the folks at the FDA and CDC. They are data-driven organizations, so I think people can be sure that when the data arrives, it will be considered appropriately and a decision will be made, ”he added.